🔎 Trials Near Me

Hjem › Bløddelssarkom › Californien

Bløddelssarkom kliniske forsøg i Californien

41 studier for Bløddelssarkom søger deltagere på steder i Californien.

Byer i Californien

Officiel studietekst (engelsk)

Distance-Based Exercise to Preserve Function and Prevent Disability

  • Kaiser Permanente Dublin, Dublin
  • Kaiser Permanente-Fremont, Fremont
  • Kaiser Permanente Fresno Orchard Plaza, Fresno
  • og 10 flere
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07059884

A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma

  • University of Southern California - Norris Cancer Center, Los Angeles
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06942442

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
  • PCR Oncology, Arroyo Grande
  • AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
  • og 20 flere
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 40 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT05334069

DESTINY-PANTUMOUR04

  • Research Site, San Diego
RekruttererObservationsstudie
Alder 18 til 130 · Alle køn · Opdateret 25. sep. 2026 · NCT07124000

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

  • Children's Hospital Los Angeles, Los Angeles
  • University of California at Los Angeles, Los Angeles
RekruttererFase 1/2
Op til 25 år · Alle køn · Opdateret 25. sep. 2026 · NCT04094610

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

  • Kivu Trial Site, Santa Monica
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT07229313

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

  • Precision NextGen Oncology and Research, Beverly Hills
  • City of Hope, Duarte
  • Valkyrie Clinical Trials, Los Angeles
  • og 3 flere
RekruttererFase 1
Alder 12 til 85 · Alle køn · Opdateret 8. sep. 2026 · NCT03715933

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

  • Stanford University, Palo Alto
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT05732831

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

  • Los Angeles General Medical Center, Los Angeles
  • USC / Norris Comprehensive Cancer Center, Los Angeles
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT05711615

Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas

  • University of California San Francisco, San Francisco
RekruttererFase 1
Alder 5 til 40 · Alle køn · Opdateret 3. sep. 2026 · NCT06156410

Actinium Therapy for Late-stage Aggressive Sarcomas

  • UCLA, Los Angeles
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 28. aug. 2026 · NCT07156565

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

  • University of California, San Francisco, San Francisco
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 25. aug. 2026 · NCT06975293

A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)

  • USC/Norris Comprehensive Cancer Center, Los Angeles
  • Sarcoma Oncology Center, Santa Monica
  • University of California Los Angeles (UCLA) - Santa Monica Cancer Care, Santa Monica
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 11. aug. 2026 · NCT06263231

A Study of MGC026 in Participants With Advanced Solid Tumors

  • The Angeles Clinic and Research Institute, Los Angeles
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 11. aug. 2026 · NCT06242470

Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors

  • Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
RekruttererTidlig fase 1
Alder 18 og opefter · Alle køn · Opdateret 31. jul. 2026 · NCT07628634

Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors

  • Zai Lab Site 02003, Los Angeles
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. jul. 2026 · NCT07374848

Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies

  • Chao Family Comprehensive Cancer Center University of California, Irvine, Orange
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 17. jul. 2026 · NCT07064018

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

  • Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 14. jul. 2026 · NCT06580002

Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)

  • University of California, Davis, Sacramento
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 8. jul. 2026 · NCT06103669

Navigation Intervention for Adolescent and Young Adult Cancer Survivors

  • KP Southern California - Department of Research & Evaluation, Pasadena
Rekrutterer
Alder 21 til 45 · Alle køn · Opdateret 6. jul. 2026 · NCT07406087

Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT Trial

  • City of Hope Medical Center, Duarte
RekruttererFase 2
Alle aldre · Alle køn · Opdateret 22. jun. 2026 · NCT07650656

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

  • Precision NextGen Oncology and Research Center, Beverly Hills
  • Sarcoma Oncology Center, Santa Monica
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 11. jun. 2026 · NCT06789172

5-Day Preoperative Radiation for Soft Tissue Sarcoma

  • Stanford University, Palo Alto
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 10. jun. 2026 · NCT06087861

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • St Joseph Heritage Healthcare, Santa Rosa
RekruttererFase 1/2
Alder 12 og opefter · Alle køn · Opdateret 27. maj 2026 · NCT03093116

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

  • Lucille Packard Children's Hospital Stanford, Palo Alto
RekruttererFase 1/2
12 Months – 30 Years · Alle køn · Opdateret 19. maj 2026 · NCT04901702

Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors

  • Stanford University, Palo Alto
RekruttererFase 1
Alder 2 til 30 · Alle køn · Opdateret 7. maj 2026 · NCT06500819

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

  • Beckman Research Institute of City of Hope, Duarte
  • VA Medical Center, Fresno, Fresno
  • Santa Clara Valley Medical Center, Fruitdale
  • og 5 flere
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 30. apr. 2026 · NCT05297734

Prospective Registry of Histotripsy for Soft Tissue Tumors

  • University of California, San Francisco, San Francisco
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 17. mar. 2026 · NCT07470008

Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort

  • UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 10. mar. 2026 · NCT02701153

Phase II Trial of Lung Chemoemobolization

  • City of Hope Medical Center, Duarte
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 5. mar. 2026 · NCT05672108

Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

  • Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 3. mar. 2026 · NCT07447050

Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)

  • Sarcoma Oncology Center, Santa Monica
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. feb. 2026 · NCT03016819

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

  • Children's Hospital of Los Angeles, Los Angeles
  • Lucile Packard Children's Hospital, Palo Alto
RekruttererFase 1/2
Alder 2 til 30 · Alle køn · Opdateret 3. feb. 2026 · NCT05734066

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • City of Hope, Duarte
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 40 og opefter · Alle køn · Opdateret 20. jan. 2026 · NCT05366881

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

  • University of Southern California, Los Angeles
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 11. dec. 2025 · NCT06943521

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

  • City of Hope, Duarte
  • UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
  • Stanford Hospital & Clinics, Stanford
RekruttererFase 1/2
Alder 15 og opefter · Alle køn · Opdateret 12. aug. 2025 · NCT06298916

SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma

  • Sarcoma Oncology Research Center, Santa Monica
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 24. feb. 2025 · NCT03138161

Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma

  • Sarcoma Oncology Center, Santa Monica
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 24. feb. 2025 · NCT03886311

BostonGene and Exigent Genomic INsight Study

  • Stockton Hematology Oncology Medical Group, Stockton
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 17. feb. 2025 · NCT06272864

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.